Letter to the Editor|Articles in Press

Omicron proliferation in the nasal cavity may explain its high infectivity

  • Daisuke Tamura
    Correspondence to: Department of Paediatrics, Jichi Medical University, 3311-1 Shimotsuke, Tochigi 329-0498, Japan.
    Department of Pediatrics, Jichi Medical University, Tochigi, Japan
    Search for articles by this author
  • Yoshihiro Kawaoka
    Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
    The University of Tokyo, Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), Tokyo 162-8655, Japan
    Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, Japan
    Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA
    Search for articles by this author
Published:March 06, 2023DOI:
      Dear Sir,
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Zheng J.
        • Wang Z.
        • Li J.
        • Zhang Y.
        • Jiang L.
        • Fu Y.
        • et al.
        High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection.
        J Infect. 2022; 84: e126-e128
        • Salvagno G.L.
        • Henry B.
        • Pighi L.
        • Nitto S.D.
        • Montagnana M.
        • Lippi G.
        SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load.
        J Infect. 2022; 84 (2022 Feb 26): 834-872
        • Marty F.M.
        • Chen K.
        • Verrill K.A.
        How to obtain a nasopharyngeal swab specimen.
        N Engl J Med. 2020; 382e76
      1. Centers for Disease Control and Prevention COVID-19. Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing. 〈〉 [Accessed 25 February 2023].

      2. National Institute of Infectious Disease, Laboratory Manuals for Pathogen Detection. Manual for the detection of pathogen; 2019. nCoV. Ver. 2.6. 〈〉; 2020 [Accessed 25 February 2023].

      3. Thermo Fisher Scientific; TaqMan. SARS-CoV-2 mutation panel USER GUIDE. 〈〉 [Accessed 25 February 2023].

      4. Centers for Disease Control and Prevention. COVID-19 isolation and precautions for people with COVID-19. 〈〉 [Accessed 25 February 2023].

      5. World Health Organization. WHO updates COVID-19 guidelines on masks, treatments and patient care. 〈〉 [Accessed 25 February 2023].

      6. Ministry of Health, Labor and Welfare. COVID-19 Q & A. 〈〉 [Accessed 25 February 2023].

        • Despres H.W.
        • Mills M.G.
        • Shirley D.J.
        • Schmidt M.M.
        • Huang M.L.
        • Roychoudhury P.
        • et al.
        Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer: RNA ratio for Delta and Epsilon vs. Alpha variants.
        Proc Natl Acad Sci USA. 2022; 119e2116518119